Recruiting studies: Hemophilia A With Inhibitor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor
Phase 4 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT05888870 Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys
Phase 4 · 1 location(s) · Runhui WU · NCT06864975 Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab
Phase N/A · 1 location(s) · Christoph Königs · NCT05802836 PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A）
Phase 4 · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT07406139 Pharmacokinetic-guided Dosing of Emicizumab
Phase 4 · 8 location(s) · Kathelijn Fischer · NCT06320626 A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A
Phase N/A · 1 location(s) · Tri-Service General Hospital (TSGH) · NCT05981274 Multidimensional Assessment of Chronic Pain in Severe Haemophilia A
Phase N/A · 1 location(s) · Investigación en Hemofilia y Fisioterapia · NCT07096349 Treatment of Hemophilia A Patients With FVIII Inhibitors
Phase N/A · 2 location(s) · Emory University · NCT04023019 SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Phase 4 · 21 location(s) · American Thrombosis and Hemostasis Network · NCT04647227 A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Phase 3 · 34 location(s) · Pfizer · NCT05611801 Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Phase 3 · 75 location(s) · Pfizer · NCT05145127

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.